The device can be used in posterior and transforaminal lumbar interbody fusions. It has the lowest insertion profile of 4mm and the greatest expansion of 18mm.
The FDA clearance allows the interbody to be used in skeletally mature patients with degenerative disc disease at one or two contiguous levels in the lumbar spine.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.